Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome
Authors

This official journal of the Japanese Society of Hematology covers all aspects of the field of hematology, namely, erythrocytes, leukocytes and hematopoiesis, hemostasis, thrombosis and vascular biology, hematological malignancies, transplantation, and cell therapy.
The International Journal of Hematology (IJH) has a long history of publishing leading research in the field. It features articles that contribute to progress in research not only in basic hematology but also in clinical hematology. The expanded Progress in Hematology section integrates such relevant fields as the cell biology of stem cells and cancer cells, and clinical research in inflammation, cancer, and thrombosis. In addition, the journal includes reports on results of clinical trials, which help foster communication among researchers in the growing field of modern hematology.
The journal provides the best of up-to-date information on modern hematology, presenting readers with high-impact, original work focusing on pivotal issues.
Color figures are free.
Why publish with us
The Japanese Society of Hematology was founded in 1937. The Society takes pride in being the second oldest hematological society in the world, next to the French Society of Hematology. The Society was approved as an incorporated association in 1990 by the Ministry of Education of Japan, with an official English language journal; International Journal of Hematology.
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Editor’s Choice Article—Enjoy Free Access